PedAM
Pediatric Disease Annotations & Medicines
| Disease | heart disease |
| Phenotype | C0948265|metabolic syndrome |
| Sentences | 25 |
| PubMedID- 22548293 | metabolic syndrome is associated with coronary heart disease (chd) and new-onset diabetes after kidney transplant (nodat). |
| PubMedID- 23479983 | [quality of life in patients with coronary heart disease associated with metabolic syndrome: results of factor analysis]. |
| PubMedID- 23091851 | Aim: to define the pharmacogenetic features of the effect of metformin in coronary heart disease (chd) patients with metabolic syndrome (ms) or type 2 diabetes mellitus (t2dm), by taking into consideration ppar-gamma2 pro1 2ala polymorphism. |
| PubMedID- 19969373 | We sought to determine whether psychological factors were associated with a greater prevalence of the metabolic syndrome in patients with coronary heart disease, and the extent to which such an association may be explained by socioeconomic status, health behaviors, and biological mediators. |
| PubMedID- 21186101 | This study evaluates the association of incident clinical coronary heart disease with metabolic syndrome and each of its individual defining components in a sample of spanish working males. |
| PubMedID- 24174878 | After an additional follow-up period of 4.9 years, coronary artery calcium progression was able to predict coronary heart disease events in patients with metabolic syndrome and without type 2 diabetes, as well as in those with type 2 diabetes. |
| PubMedID- 23251156 | The increased risk of coronary heart disease in patients with the metabolic syndrome suggests that the insulin-resistant state is atherogenic without concomitant elevations in plasma glucose and glycosylated hemoglobin [26, 27]. |
| PubMedID- 24793349 | Background and objectives: to evaluate the risk of coronary heart disease (chd) associated with metabolic syndrome (mets) and its individual components in a representative sample of diabetic and nondiabetic iranians. |
| PubMedID- 22323895 | A widely held view is that large hdl2 particles are atheroprotective.27 the role of hdl3 particles in preventing atherogenesis on the other hand is less clear.27,28 some studies have reported that hdl3 is significantly associated with coronary heart disease, particularly in patients with metabolic syndrome because small hdl particles coincide with low hdl cholesterol levels and can be functionally compromised in patients with metabolic syndrome.4,16 other studies associate the small hdl3 particle with atheroprotective functions, including an ability to mature into larger hdl2 and promote reverse cholesterol transport, and to antagonize and inhibit inflammation and oxidation within blood vessel walls.29–31 discordance in these data may reflect the complex relationships between hdl subclasses, methods of fractionation, physiological versus pathological conditions (such as metabolic diseases or presence of coronary artery disease), or treatment effects with different lipid-modifying drugs. |
| PubMedID- 21153653 | Obesity does not appear to be an independent predictor for the 10-year risk of coronary heart disease events in patients without metabolic syndrome treated with second-generation antipsychotics. |
| PubMedID- 23819342 | [comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome]. |
| PubMedID- 20940070 | Objective: we examined the risk of cardiovascular disease, stroke, ischaemic heart disease, and diabetes with the metabolic syndrome according to the new harmonised definition and its components using a national longitudinal data set from an asian population. |
| PubMedID- 22497433 | These are risk factors for heart disease and are associated with obesity, metabolic syndrome, and diabetes—all considered health risks of night-shift work. |
| PubMedID- 22355990 | Frequency of metabolic syndrome in patients with ischaemic heart disease. |
| PubMedID- 21139493 | Procollagen iii n-terminal peptide predicts short-term prognosis and cardiac remodeling in coronary heart disease patients with metabolic syndrome. |
| PubMedID- 21151616 | Unlike class i and iia hdacs, class iii hdacs play an important role in regulating oxidative stress in heart diseases with metabolic syndromes. |
| PubMedID- 25951087 | Low occupational prestige has also been associated with metabolic syndrome, greater risk of coronary heart disease in men, and total mortality from any cause, cancer, cardiovascular diseases, and respiratory diseases [13–15]. |
| PubMedID- 22323866 | Visceral fat is independently related to morbidity and mortality of the coronary heart disease and associated with metabolic syndrome, diabetes, and cardiovascular disease. |
| PubMedID- 21636030 | We also discuss that a healthy lifestyle is essential for preventing and treating chronic kidney disease and coronary heart disease seen in patients with metabolic syndrome. |
| PubMedID- 20956003 | Obesity and metabolic syndrome increase the risk of coronary heart disease and lead to a proinflammatory state of the vascular wall. |
| PubMedID- 19935427 | The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease. |
| PubMedID- 26274823 | The relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function--an occupational cohort-based study. |
| PubMedID- 24871476 | Intervention and prospective research suggests that diets that include beans reduce low-density lipoprotein cholesterol, favorably affect risk factors for metabolic syndrome, and reduce risk of ischemic heart disease and diabetes. |
| PubMedID- 26401840 | Correction: the relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function - an occupational cohort-based study. |
| PubMedID- 22780328 | Introduction: excessive abdominal obesity along with other risk factors results in the metabolic syndrome, which can lead to heart disease, type-2 diabetes, and death. |
Page: 1